AB0396 Tocilizumab i.v. Effectiveness in Ra Patients Is Independent of Smoking Status

doi 10.1136/annrheumdis-2017-eular.5923
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

From Patients With Arthralgia, Pre-Ra and Recently Diagnosed RA: What Is the Current Status of Understanding RA Pathogenesis?

RMD Open
RheumatologyAllergyImmunology
2018English

PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

FRI0213 Comparative Effectiveness of Abatacept, Rituximab, Tocilizumab and Anti-TNF Biological Dmards in Ra: Results From the Nationwide Swedish Register

2017English

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Figure 4: Model Evaluation Using an Independent Patient Set of 87 RA Patients With PF and an External Validation Set of 218 RA Patients.

English

Co1 Comparative Effectiveness Analysis of TNF Blockers in Rheumatoid Arthritis (Ra) Patients in a Real-World Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Comparison in the Oral Status Among 123 Smoking and Non-Smoking Premenopausal and Menopausal Patients

Romanian Journal of Orthopaedic Surgery and Traumatology
2018English

Deferoxamine Inhibition of Malaria Is Independent of Host Iron Status

Journal of Experimental Medicine
MedicineAllergyImmunology
1988English

Cigarette Smoking Is an Independent Risk Factor for Post-Stroke Delirium

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy